|

Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma

RECRUITINGSponsored by AdventHealth
Actively Recruiting
SponsorAdventHealth
Started2026-11-01
Est. completion2028-05-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
Locations1 site

Summary

The goal of this observational study is to evaluate whether hepatic artery infusion pump (HAIP) chemotherapy can improve outcomes in patients with pancreatic or duodenal adenocarcinoma who have isolated or liver-dominant metastases after surgery and systemic chemotherapy. The main questions it aims to answer are: Does HAIP chemotherapy improve liver tumor response based on imaging criteria (RECIST)? What are the progression-free survival and overall survival outcomes in this patient population? Participants will: Undergo placement of a hepatic artery infusion pump as part of standard clinical care Receive floxuridine (FUDR)-based chemotherapy through the pump Have clinical data, imaging results, and laboratory markers (e.g., ctDNA, CEA, CA 19-9) collected from their medical records over time

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 18-80 years
* Histologically confirmed pancreatic or duodenal adenocarcinoma
* Completed or currently receiving curative-intent treatment
* Evidence of isolated or liver-dominant metastases (radiographic or clinical)
* Deemed clinically eligible for hepatic artery infusion pump (HAIP) placement and floxuridine (FUDR)-based chemotherapy by a multidisciplinary oncology team
* Scheduled for HAIP placement at AdventHealth Orlando

Exclusion Criteria:

\- Patients who are clinically ineligible for HAIP placement or FUDR therapy are excluded

Conditions8

Ampullary AdenocarcinomaCancerDuodenal AdenocarcinomaDuodenal CancerLiver CancerLiver DiseasePancreas AdenocarcinomaPancreas Cancer With Hepatic Metastase

Interventions1

Locations1 site

AdventHealth Orlando

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.